Vanguard Global Advisers »

Oric Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $505k 40k 12.67

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Oric Pharmaceuticals

Nextech Invest
EcoR1 Capital
BlackRock
Viking Global Investors
Pfizer
Vanguard Group
Sr One Capital Management
Alkeon Capital Management
VR Adviser
State Street Corporation
NEA Management Company
Vanguard Capital Management
Column Group
OrbiMed Advisors
FMR

View all funds holding Oric Pharmaceuticals